| Emerging risk biomarkers in cardiovascular diseases and disorders | 7,087 |
| The correlation of dyslipidemia with the extent of coronary artery disease in the Multi-Ethnic Study of Atherosclerosis | 3,540 |
| Safety and Efficacy of Extremely Low LDL-Cholesterol levels and Its Prospects in Hyperlipidemia Management | 3,124 |
| Beneficial role of Bitter melon supplementation on obesity and related complications in metabolic syndrome | 2,822 |
| Cardiovascular outcomes of PCSK9 inhibitors: with special emphasis on its effect beyond LDL-cholesterol lowering. | 2,694 |
| SPHINGOLIPID METABOLIC PATHWAY - AN OVERVIEW OF MAJOR ROLES PLAYED IN HUMAN DISEASES | 2,559 |
| Identification and quantification of fatty acids in T. viridissima, C. biguttulus and C. brunneus by GC-MS | 2,365 |
| Non-alcoholic fatty liver disease: focus on lipoprotein and lipid deregulation | 1,844 |
| Antibacterial activity of free fatty acids from hydrolyzed virgin coconut oil using lipase from candida rugosa. | 1,488 |
| Comparison of low-dose rosuvastatin with atorvastatin in lipid-lowering efficacy and safety in a high-risk Pakistani cohort: an open-label randomized trial. | 1,464 |
